The table below shows Terns Pharmaceuticals, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Q1 2020
Operating cash flow
-$24.44M
-$22.80M
-$14.38M
-$13.30M
-$14.32M
-$7.29M
Capital expenditure
$0.00
$29.00K
$0.00
$242.00K
$24.00K
$430.00K
Investing cash flow
$1.96M
$8.00M
$27.93M
$9.49M
-$96.82M
$6.85M
Dividends paid
-
-
-
-
TERN operating cash flow (10-K history)
Terns Pharmaceuticals, Inc. reported operating cash flow of -$82.18M for fiscal year 2025. That is down 17.4% from -$70.02M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$29.81M (FY 2020) to -$82.18M. Figures come from the company's audited annual reports as filed with the SEC.
